05.10.2015 • NewsDede WillamsBASFcapacity expansion

BASF Expands Biological Solutions for Agriculture

BASF has expanded its production site at Littlehampton, UK, to meet growing global demand for biological solutions for agriculture and horticulture. Capacity for beneficial nematodes and inoculants has been doubled, in line with the German group’s strategy to develop solutions beyond conventional crop protection.

Beneficial nematodes are microscopic organisms that can control a diverse range of insect and slug pests. BASF’s portfolio includes six different types, including the Nemaslug and Nemasys products, each with a distinctive mode of action for customers in vegetable, horticulture and turf.

“Demand for our beneficial nematodes has increased significantly over the past five years, with 2014 being our best year to date,” said Graeme Gowling, responsible for global biologicals, marketing in Functional Crop Care. He added that BASF’s customers see an increasingly important role in using these in Integrated Pest Management (IPM) programs, as they are easy to apply, have a longer window of activity and can effectively control yield-robbing pests.

Additionally, the newly expanded Littlehampton site will increase the supply of inoculants from BASF worldwide and especially to Europe and Africa. These rhizobia bacteria have a symbiotic relationship with their host legume plants and produce root nodules to conduct nitrogen fixation. BASF produces biological inoculants as an ingredient for seed treatments to enhance seed health, plant vitality and yield potential.

“This development will advance our market leader position in high-quality seed treatment. Along with the production investments in Littlehampton and additional sites globally, we will continue strengthening our R&D and portfolio,” said Philipp Rosendorfer, vice president R&D Functional Crop Care.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.